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Oxidative stress has been implicated to play a role, at least in part, in pathogenesis of many disease conditions and toxicities in
animals. Overproduction of reactive oxygen species and free radicals beyond the cells intrinsic capacity to neutralize following
xenobiotics exposure leads to a state of oxidative stress and resultant damages of lipids, protein, and DNA. Lead and cadmium are
the common environmental heavy metal pollutants and have widespread distribution. Both natural and anthropogenic sources
including mining, smelting, and other industrial processes are responsible for human and animal exposure. These pollutants,
many a times, are copollutants leading to concurrent exposure to living beings and resultant synergistic deleterious health eﬀects.
Several mechanisms have been explained for the damaging eﬀects on the body system. Of late, oxidative stress has been implicated
in the pathogenesis of the lead- and cadmium-induced pathotoxicity. Several ameliorative measures to counteract the oxidative
damage to the body system aftermath or during exposure to these toxicants have been assessed with the use of antioxidants. The
presentreviewfocusesonmechanismoflead-andcadmium-inducedoxidatedamagesandtheameliorativemeasurestocounteract
the oxidative damage and pathotoxicity with the use of supplemented antioxidants for their beneﬁcial eﬀects.
1.Introduction
The diverse deleterious health eﬀect upon exposure to
toxic heavy metals in the environment is a matter of
serious concern and a global issue. Much emphasis has
been given to elucidate the mechanism of toxicity due to
common environmental toxicants and to develop a safer
chemotherapeutic approach to mitigate the toxic eﬀects.
Lead and cadmium are the two most abundant toxic metals
in the environment. The coexposure to these two toxic
metals has synergistic cytotoxicity that may, at times, turn
to antagonistic eﬀects, because exposure to higher mixture
concentrations may enhance cellulardefense mechanisms [1,
2], including induction of metallothioneins synthesis upon
exposure to cadmium. The concurrent higher levels of lead
and cadmium have been recorded in several ﬁeld situations.
The common sources of lead and cadmium are diverse in
nature including natural and anthropogenic processes such
as combustion of coal and mineral oil, smelters, mining and
alloy processing units, paint industries, and so forth. [2–5].
The quantity of lead used in the present decade far exceeds
the total amount consumed in all previous eras [2]. The
anthropogenic activities and vehicular emissions contribute
to the entry of toxic metals to humans and other animals
food chains [6].
Cadmium is an important environmental pollutant
present in soil, water, air and food. Anthropogenic sources
add 3–10 times more cadmium to the atmosphere than
natural sources [7]. Major occupational exposure occurs
from nonferrous smelters during production and processing
of cadmium, its alloys, and compounds, and the exposure is
increasingly common during recycling of electronic waste.
Lead and cadmium do not have any detectable beneﬁcial
biological roles. On the contrary, their detrimental eﬀects
on physiological, biochemical, and behavioral dysfunctions
have been documented in animals and humans by several2 Veterinary Medicine International
investigators [8, 9] .T h eh i g h e rl e v e l sa ﬀect the central and
peripheral nervous systems [10], haemopoietic system [11],
cardiovascular system [12], kidneys [13], liver [14], and
reproductive systems [15, 16]. Cadmium is more toxic than
leadandcausesrenalandhepaticdamageinexposedanimals
[13, 14].
Of late, lead- and cadmium-induced tissue damages
have been attributed, at least in part, to toxicant-induced
oxidative stress [17, 18]. Cadmium stimulates the formation
of metallothioneins and reactive oxygen species (ROS), thus
causing oxidative damage to erythrocytes and various tissues
resulting in loss of membrane functions [19]. Long-term
exposure to Cd increases lipid peroxidation and causes
inhibition of SOD activity indicating oxidative damage in
liver,kidneyandtestes[20].Thevarioustoxiceﬀectsinduced
by Cd in biological systems have been linked to increased
lipid peroxidation, an as early and sensitive consequence
of Cd exposure. The increase in lipid peroxidation due
to Cd toxicity have been attributed to alterations in the
antioxidant defense system which includes enzymes such
as glutathione peroxidase (GPx), glutathione-S-transferase,
superoxide dismutase (SOD), and catalase (CAT), and
nonenzymatic molecule like glutathione, which normally
protect against free radical toxicity.
2.Lead-InducedOxidativeStress
The mechanism of lead-induced oxidative stress involves an
imbalance between generation and removal of ROS (reactive
oxygen species) in tissues and cellular components causing
damage to membranes, DNA and proteins. The presence of
double bonds in the fatty acid on cell membrane weakens
the C–H bonds on the carbon atom adjacent to the double
bonds and makes H removal easier. Therefore, fatty acids
containing zero to two double bonds are more resistant
to oxidative stress than polyunsaturated fatty acids with
more than two double bonds [21]. The above fact was
substantiated after incubation of linoleic, linolenic, and
arachidonic acid with lead in which the concentration of a
ﬁnal product of oxidative stress, malondialdehyde (MDA)
was increased with the number of double bonds of fatty acid
[22].
Theintrinsicmechanismunderlyinglead-inducedoxida-
tive damage to membranes is associated with changes
in its fatty acid composition [23]. The fatty acid chain
length and unsaturation are the determinant for membrane
susceptibility to peroxidation, and lead induced arachidonic
acid elongation might be responsible for the enhanced
lipid peroxidation of the membrane [24]. Thus, lead aﬀects
membrane-related processes such as the activity of mem-
brane enzymes, endo- and exocytosis, transport of solutes
across the bilayer, and signal transduction processes by
causing lateral phase separation [25].
Lead accumulation in tissues causes oxidative DNA
damages including strand break, although the evidence of
lead-induced oxidative damage to DNA is less conclusive
[18]. The δ-aminolevulinic acid dehydrase (ALAD) is highly
sensitive to the toxic eﬀects of lead [26]. The accumulation
of δ-aminolevulinic acid (ALA) upon exposure to lead
induces generation of ROS [27, 28] and resultant oxidative
stress [29]. The ﬁnal oxidation product of ALA, 4,5-
dioxovaleric acid is an eﬀective alkylating agent of the qui-
nine moieties within both nucleoside and isolated DNA[30].
Increased level of 8-oxo-7, 8-dihydro-2-deoxyguanosine
and5-hydroxyl-2-deoxycytidinefollowingchronictreatment
with ALA in rats has been attributed for ALA-induced DNA
damage [31]. There are recent data suggesting lead-induced
alteration in gene expression [32] and it appears to interact
with zinc-binding sites on an important DNA-associated
protein, human protamine [33].
The eﬀect on the antioxidant defense systems of cells
is the second mechanism for lead-induced oxidative stress.
Lead and other metals such as Hg and Cd have a high aﬃnity
for sulfhydryl (SH) groups. Mercaptides are formed with the
SHgroupofcysteine,thatarelessstablecomplexes[34].Lead
is shown to alter antioxidant activities by inhibiting func-
tional SH groups in several enzymes such as ALAD, superox-
ide dismutase (SOD), catalase (CAT), glutathione peroxidase
(GPx), and glucose-6-phosphate dehydrogenase (G6PD)
[35–38]. G6PD contains many SH group and supplies cells
with most of the extramitochondrial NADPH through the
oxidation of glucose-6-phosphate to 6-phosphogluconate.
G6PD is inhibited by lead [39]. However, there are more
complex eﬀects of lead on G6PD, as evidenced by in vivo
studies. G6PD activity increases in RBCs of lead-treated rats
[40] and lead-exposed workers [41]. The most important
regulation of the pentose phosphate pathway is the NADP-
/NADPH ratio, which is known to change in favor of the
oxidized form under oxidative stress conditions. Therefore,
lead exposure results in an increase or decrease in G6PD
activitydependingontheconcentrationanddurationoflead
exposure, and magnitude of oxidative stress inside the cell
[42].
GPx, CAT, and SOD are potential targets for lead toxicity
because these antioxidant enzymes depend on various
essential trace elements for proper molecular structure and
activity [43]. Since lead-associated reduction in selenium
uptake may increase the susceptibility of the cell to oxidative
stress, an antagonistic eﬀect between selenium and lead was
found to aﬀect GPx activity that requires selenium as a
cofactor [44].Ontheotherhand,administrationofselenium
beforeleadexposureproducessigniﬁcantprophylacticaction
against lead-induced oxidative stress by means of increasing
SOD, glutathione reductase (GR) activity, and glutathione
(GSH) content in male rats [45]. In summary, impaired
antioxidant defenses can be a result of the inhibitory eﬀects
of lead on various enzymes, which in turn causes the cells to
be more susceptible to oxidative insult.
3. Cadmiumand OxidativeStress
Cadmium is a well-recognized environmental pollutant with
numerous adverse health eﬀects. It principally aﬀects lung,
liver, kidney, and testes following acute intoxication, and
nephrotoxicity, immunotoxicity, osteotoxicity and tumors
on prolong exposures. Reactive oxygen species (ROS) are
often implicated in Cd-induced deleterious health eﬀects.
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in animals following acute Cd overload, and indirect evi-
dence of involvement of ROS in chronic Cd toxicity and
carcinogenesis. Cd-generated superoxide anion, hydrogen
peroxide, and hydroxyl radicals in vivo have been detected
by the electron spin resonance spectra, which are often
accompanied by activation of redox sensitive transcription
factors (e.g., NF-κB, AP-1 and Nrf2) and alteration of ROS-
related gene expression. It is generally agreed upon that
oxidative stress plays important roles in acute Cd poisoning.
However, direct evidence for oxidative stress is often
obscure following long-term and environmentally-relevant
low levels of Cd exposure. Alterations in ROS-related gene
expression during chronic exposures are also less signiﬁcant
compared to acute Cd poisoning. This is probably due
to induced adaptation mechanisms such as overexpression
of metallothionein and glutathione following chronic Cd
exposures, which in turn diminish Cd-induced oxidative
stress. In chronic Cd-transformed cells, less ROS signals
are detected with ﬂuorescence probes. Acquired apoptotic
tolerance renders damaged cells to proliferate with inherent
oxidative DNA lesions, potentially leading to tumorogenesis.
Thus, ROS are generated following acute Cd overload that
play an important roles in tissue damage. Adaptation to
chronic Cd exposure reduces ROS production, but acquired
Cd tolerance with aberrant gene expression plays important
roles in chronic Cd toxicity and carcinogenesis.
The basic mechanisms involved in cadmium carcinogen-
esis are gene regulation of proto-oncogenes [46], oxidative
stress [47–51], disruption of cadherins, inhibition of DNA
repair and interference with apoptosis [52]. Cadmium
is a potent cell poison, and known to cause oxidative
stress by increasing lipid peroxidation and/or by changing
intracellular glutathione levels. It aﬀects the ubiquitin/ATP-
dependent proteolytic pathway. However, the cellular mech-
anisms involved in cadmium toxicity are still not well
understood, especially in neuronal cells. The treatment of
neuronal cells culture with diﬀerent concentrations of the
metal ion to examine the relationship between cadmium-
induced oxidative stress and the ubiquitin/ATP-dependent
pathway revealed decreased glutathione levels, and marked
increases in protein-mixed disulﬁdes (Pr-SSGs) [53]. The
increases in intracellular levels of Pr-SSGs were concurrent
with increases in the levels of ubiquitinated proteins (Ub
proteins) when the HT4 cells were subjected to lower
(25μm or less) concentrations of cadmium. However, higher
concentrations of cadmium (50μm) led to increases in
Pr-SSGs but inhibited ubiquitination, probably reﬂecting
inhibition of ubiquitinating enzymes.
The cadmium-induced changes in Pr-SSGs and Ub pro-
teins are not aﬀected when more than 85% of intracellular
glutathione is removed from the cells by the glutathione
synthetase inhibitor l-buthionine-(S, R)-sulfoximine. How-
ever, the reducing agent dithiothreitol, that prevents build-
up of Pr-SSGs in the cell also blocks the accumulation of
Ub proteins induced by cadmium. In addition, dithiothreitol
blocks the eﬀects of higher (50μm) concentrations of cad-
mium on cytotoxicity and on glutathione, Pr-SSGs, and Ub
proteins. Together, these resultsstrongly suggestthat changes
in the levels of intracellular Pr-SSGs and ubiquitin-protein
conjugates in neuronal cells are the responses closely
associated with the disruption of intracellular sulfhydryl
homeostasis caused by cadmium-mediated oxidative stress.
The testis is the important target organ of Cd toxicity.
Many studies indicate that Cd induces testicular damage in
many species of animals including mice, hamsters, rabbits,
guinea pigs and dogs [54, 55]. Cadmium has profound
eﬀect on sex organ weight, a primary indicator of possible
alterationin androgenstatus[56,57].Severalmechanismsof
Cd-induced testicular toxicity have been proposed. Lafuente
et al. [58] reported increased Cd accumulation in the
hypothalamus, pituitary, and testis and decreased plasma
levels of follicle stimulating hormone in rats, suggesting a
possibleeﬀectofCdonthehypothalamic-pituitary-testicular
axis.
Several studies also suggest participation of reactive
oxygen species (ROS) in Cd-induced testicular damage [59].
Both acute and chronic Cd exposure is associated with
elevated lipid peroxidation in the lung, brain, kidney, liver,
erythrocytes, and testis [60–64]. The reactive oxygen species
(ROS) play both beneﬁcial and harmful roles in living
organisms [65]. ROS can be generated by both exogenous
and endogenous sources. Cadmium is one of the exogenous
sources shown to indirectly produce ROS in various cell
lines [66–68]. The production and accumulation of ROS
inhibit the electron transfer chain in mitochondria [69]. In
general,the accumulatedROSconsists of various amounts of
hydrogenperoxide,hydroxylions,singletoxygen,superoxide
anions, lipid hydroperoxides, phospholipid hydroperoxides,
and so forth. Excessive production of ROS disturbs the
balance between the ROS and antioxidant agents (enzymes
and antioxidant substances) in the cells. Hydrogen peroxide
is the common substrate for catalase and GPx enzymes
in the cells. While catalase decomposes H2O2 into water
and oxygen, GPx oxidizes GSH to GSSG by utilizing H2O2.
Glutathione reductase (GR) is another enzyme required for
the antioxidant defense mechanism in cells. It reduces GSSG
into GSH. Both GPx and GR work in tandem in the cells in
order to maintain the GSH/GSSG ratio at a steady state level.
When the cells are under oxidative stress, catalase, GR and
GPx respond by altering their activities.
4. Amelioration of Lead- and
Cadmium-InducedOxidativeStress
Abetment of lead and cadmium toxicity with rebalancing the
impaired prooxidant/antioxidant ratio through supplemen-
tation of antioxidant nutrients are still not completely clear.
However, evidences suggest signiﬁcant protective eﬀects
of antioxidant nutrients such as vitamin-C, carotenoids,
selenium, vitamin-E, and so forth.
Vitamin C is a major antioxidant that scavenges the
aqueous ROS by very rapid electron transfer that inhibits
lipid peroxidation [21]. Administration of vitamin C sig-
niﬁcantly inhibits the lipid peroxidation levels of liver and
brain,andincreasedtheCATlevelsofkidneyinlead-exposed
rats [17]. Lead-induced ROS production as examined by
rat sperm chemiluminescence generation reduced by 40%
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[70]. Vitamin C supplementation in lead-exposed animals
signiﬁcantly reduces blood, liver, and renal lead levels,
and associated biochemical changes indicating a signiﬁcant
protective action of vitamin C against toxic eﬀects of lead on
heme synthesis and drug metabolism [71]. The combination
of vitamin C and thiamine have been proved eﬀective in
reducing lead levels in blood, liver, and kidney along with
reduction in lead-induced inhibition in the activity of blood
d-ALAD and blood zinc protoporphyrin [72].
There has been considerable debate concerning the
relationship between vitamin C nutritional status and lead-
induced toxic eﬀects. Early reports suggest vitamin C as a
possible chelator of lead, with similar potency to that of
EDTA [8]. Vitamin and/mineral supplementation in African
Americanwomenwasfoundtoreducebloodleadlevel(BLL)
from 5.1 to 1.1mg/dl, which was negatively correlated with
serum levels of vitamin E and C [73]. Ascorbic acid increases
urinaryeliminationofleadandreducesthehepaticandrenal
lead burden in rats [74].
A cross-sectional study analyzed 4213 young and 15365
adult Americans with mean BLL of 2.5–3.5mg/dl, respec-
tively. The BLL had inverse relationship with serum vita-
min C [75]. Vitamin C supplementation resulted in small
reductions in lead retention in 85 human volunteers who
consumed a lead-containing drink [76]. However, workers
occupationally exposed to lead, and with BLL ranged from
28.9 to 76.4mg/dl, supplementation of vitamin C and
zinc did not signiﬁcantly reduce BLL [77]. The vitamin C
supplementation did not alter the blood and sperm lead
levels in lead-treated rats with BLL of 36mg/dl [70]. A recent
report stated that rats treated with ascorbic acid did not
reduce lead burden in the liver, kidney, brain, and blood
[17]. Although it is biologically plausible that vitamin C
may aﬀect lead absorption and excretion, the eﬀect is more
obvious in low-exposed subjects with higher vitamin C
supplementation. In humans and animals exposed to high
levels of lead, the reduction of BLL by vitamin C is less
signiﬁcant.
Vitamin E is the generic term used to describe at least
eight natural-occurring compounds that possess the bio-
logical activity of α-tocopherol. The group is comprised of
α-, β-, γ-a n dδ-tocopherol and α-, β-, γ-a n dδ-tocotrienol.
RRR-α-tocopherol has the highest biological activity [78],
the other tocopherols and tocotrienols are less biologically
active but they are at least as abundant as α-tocopherol
in certain foods [79]. Vitamin E is nature’s major lipid
soluble chain-breaking antioxidant that is known to protect
biological membranes and lipoproteins from oxidative stress
[80]. The main biological function of vitamin E is its
direct inﬂuence on cellular responses to oxidative stress
through modulation of signal transduction pathways [81].
One of the protective roles of vitamin E on lead-induced
damage is prevention of lipid peroxidation and inhibition
of SOD and CAT activities in liver [82]. In lead-exposed
rats, supplementation of vitamin E and/or C reduced sperm
ROS generation, prevented loss of sperm motility and oocyte
penetrationcapacity[70].TheinteractionbetweenvitaminE
andotherantioxidantsmighthaveamoreeﬃcientprotective
action against lead toxicity. Vitamin E and C jointly protect
lipid structures against peroxidation [83]. Although vitamin
E is located in membranes and vitamin C in aqueous phases,
vitamin C is able to recycle oxidized vitamin E [84]. Vitamin
C repairs the tocopherol radical, thus recovering the chain-
breaking antioxidant capacity of vitamin E [83]. Vitamin
E alone or in combination with conventional chelator,
CaNa2EDTA has been reported to decrease the lead-induced
lipid peroxide levels in liver and brain in rats [17].
Carotenoids play a signiﬁcant role in reduction of lead-
induced stress in all species. The reaction of carotenoids
with radicals is partly due to its roles in photosynthesis,
thus electron transfer from β-carotene to P680, with the
β-carotene being oxidized to its radical cation CAR [85].
Dietary β-carotene mediates prevention of lipid peroxida-
tion, and reduces the incidence of many diseases including
cancer, atherosclerosis, age-related macular degeneration,
and multiple sclerosis [86, 87]. However, the generally
accepted beneﬁcial roles of carotenoids as antioxidants have
been seriously challenged by the results from clinical trials
that suggest deleterious eﬀects of administered β-carotene
in heavy smokers [88] .T h e r eh a v eb e e nc o n s i d e r a b l er e c e n t
investigations in the interaction of β-carotene and other
antioxidants [89].
The antioxidant eﬀects of Spirulina fusiformis,b l u e g r e e n
algae rich in β-carotene and SOD, against lead toxicity
have been examined in the testes of Swiss mice. The
antioxidant nutrients scavenged the free radicals after lead
administration and ROS generation in mice testes [90]. Sup-
plementation with multiple antioxidants including vitamin
C, vitamin E, β-carotene, selenium, and zinc resulted in
signiﬁcant increase of SOD and GPx in 36 workers exposed
to lead [91]. The interaction of carotenoids and carotenoid
radicalswithotherantioxidantsisofimportancewithrespect
to anti- and, possibly, pro-oxidative reactions of carotenoids.
The nature of the reaction between the tocopherol (TOH)
andvariouscarotenoidsshowsamarkedvariationdepending
on the speciﬁc tocopherol homologue, of which a-TOH is
the most active. β-carotene radical interacts with vitamin C
in the aqueous phase, and carotenoid radical are eﬃciently
reconverted to the parent carotenoid by vitamin C [89, 92].
Interactionsbetweenzincandleadhavebeeninvestigated
at absorptive and enzymatic sites [93]. Zinc and lead
compete for similar binding sites on the metallothionein-
like transport protein in the gastrointestinal tract [94].
The competition between zinc and lead might decrease
the absorption of lead, thus reducing lead toxicity. Dietary
supplementationwithzincandincombinationwithascorbic
acid [95] and thiamine [96] reduces lead toxicity in humans.
Zinc has an important role in spermatogenesis in the male
reproductive system, and the most probable site of action is
the primary spermatocyte. Zinc supplementation competes
for and eﬀectively reduces the availability of binding sites
for lead uptake. In another study, zinc was administrated to
lead-exposed rats along with chelating agents CaNa2EDTA,
succimer, and D-penicillamine. Zinc enhanced the eﬃcacy
of lead chelation by reducing the blood, hepatic and renal
lead level, and overturning the inhibited activity on blood
ALAD [97]. A recent study has shown prevention of δ-
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lead-exposed rats following zinc supplementation [98]. The
protective eﬀects of zinc against testicular damage caused by
lead might be due to competition between lead and zinc.
There is still no strong and direct evidence to conclude that
the beneﬁcial eﬀects of zinc are mediated by antioxidation.
Zinc is a trace element essential for living organisms.
More than 300 enzymes require Zn for their activity. It plays
an important role in the DNA replication, transcription, and
protein synthesis, inﬂuencing cell division and diﬀerentia-
tion [99]. Zn has a relationship with many enzymes in the
body and can prevent cell damage through activation of the
antioxidant system [100–102]. It is an essential component
of the oxidant defense system and functions at many levels
[103]. Zn deﬁciency increases lipid peroxidation in various
rat tissues, whereas Zn supplementation corrects the impair-
ment [102]. Cotreatment with Cd and Zn prevents damage
to the testes from Cd exposure [104]. This suggests Cd inter-
ference in Zn-related metabolic functions. The competitive
mechanism of interaction and Zn-induced metallothionein
induction are the plausible mechanism behind protective
eﬀects of Zn against Cd toxicity. This is substantiated by
the ﬁndings that Cd treatment decreases the testicular Zn
concentration and elevates the levels of hepatic and renal
metallothioneins [105]. Zn pretreatment can prevent of
cadmium-inducedtesticulartumorswhichmaybeattributed
to the ability of Zn to reduce the cytotoxicity of Cd in
interstitial cells by enhancing eﬄux of Cd and decreasing
accumulationofCdinthenucleiofthistargetcellpopulation
in the rat testis [106]. So, Cd altered testicular function
mediated through induction of oxidative stress could be
reversed by administration of Zn.
Selenium is a cofactor of GPx, a cyto-antioxidant
enzyme. Selenium enhances the availability of GSH, which is
one of the most abundant intrinsic antioxidants that helps in
preventinglipidperoxidationandresultantcelldamage.Lead
exposure decreases the activity of GPx due to the interaction
of lead with the essential selenocysteine moiety of the
enzyme [107]. Protection against liver and kidney damage
by selenium is attributed to enhanced antioxidant capacity
of cells, as evidenced by increased SOD and GR activities and
elevated GSH content following selenium supplementation
[45]. The combination of selenium and other antioxidants
has been shown to reduce oxidative stress in animals. DNA
damage in the liver and spleen induced by fumonisin B1 was
protected by the mixture of antioxidants coenzyme Q10, L-
carnitine, vitamin E and selenium in rats [108]. Combined
administration of antioxidants containing selenium, vitamin
C, vitamin E, β-carotene, and N-acetyl cysteine has been
reported to prevent both the diabetes- and galactosemia-
inducedelevationofoxidativestressinrats[109].Despitethe
above ﬁndings, the beneﬁcial role of selenium alone on lead-
induced oxidative stress is still unclear in human studies.
5. Conclusion
Generation of highly reactive oxygen species aftermath
of lead and cadmium exposure may result in systematic
mobilization and depletion of the cell intrinsic antioxi-
dant defenses. Formation of reactive oxygen intermediates
beyond the scavenging capacity of these antioxidant defense
mechanisms results in accumulation of harmful free radicals
and likelihood of oxidative damage to critical biomolecules,
such as enzymes, proteins, DNA, and membrane lipids.
Several mechanisms have been proposed to mediate the
oxidative stress caused by lead and cadmium, including
disrupted pro-oxidant/antioxidant balance. Although many
investigators have shown lead-induced oxidative damage,
and some antioxidants were found to reduce lead toxicity,
the mechanisms of dietary supplementation of antioxidants
remain to be further clariﬁed in lead-exposed humans or
animals.
Evidences suggest that in presence of varying concen-
trations of cadmium, the mitochondrial enzymes are more
eﬀective in reducing various ROS than their cytoplasmic
counterparts. This observation reveals that most oxido-
reduction reactions take place in the mitochondria, leading
to the formation of several ROS. As less ROS are produced
in the cytoplasm, the activities of antioxidant enzymes in the
cytoplasmarenotashighasthemitochondrial enzymeswith
cadmiumtreatments.Thus,moreoxidativestressisobserved
in the mitochondria than in the cytoplasm. Each antioxidant
enzyme shows its own pattern of activation or inhibition
uponexposureofcellstodiﬀerentconcentrationsofleadand
cadmium.
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